FDA approves Pfizer’s rheumatoid arthritis treatment
Nov 14, 2012
Federal regulators recently approved Pfizer’s new Xeljanz treatment for rheumatoid arthritis. Xeljanz was approved for patients with moderate to severe rheumatoid arthritis who did not benefit from...
Pfizer gets FDA approval for rheumatoid arthritis treatment
By
McKnight's Staff
Nov 09, 2012
Federal regulators approved Pfizer’s new Xeljanz treatment for rheumatoid arthritis Tuesday. The potentially lucrative drug is now poised to enter a market that already features Humira, Abbott Laboratories’...